Your browser doesn't support javascript.
loading
Predictive value of serum protein levels in patients with advanced non-small cell lung cancer treated with nivolumab.
Oyanagi, Jun; Koh, Yasuhiro; Sato, Koichi; Mori, Keita; Teraoka, Shunsuke; Akamatsu, Hiroaki; Kanai, Kuninobu; Hayata, Atsushi; Tokudome, Nahomi; Akamatsu, Keiichiro; Nakanishi, Masanori; Ueda, Hiroki; Yamamoto, Nobuyuki.
Afiliación
  • Oyanagi J; Internal Medicine III, Wakayama Medical University, 811-1, Kimiidera, Wakayama-city, Wakayama, 641-8501, Japan.
  • Koh Y; Internal Medicine III, Wakayama Medical University, 811-1, Kimiidera, Wakayama-city, Wakayama, 641-8501, Japan. Electronic address: ykoh@wakayama-med.ac.jp.
  • Sato K; Internal Medicine III, Wakayama Medical University, 811-1, Kimiidera, Wakayama-city, Wakayama, 641-8501, Japan.
  • Mori K; Clinical Research Support Center, Shizuoka Cancer Center, 1007 Shimonagakubo Nagaizumi-cho, Sunto-Gun, Shizuoka, 411-8777, Japan.
  • Teraoka S; Internal Medicine III, Wakayama Medical University, 811-1, Kimiidera, Wakayama-city, Wakayama, 641-8501, Japan.
  • Akamatsu H; Internal Medicine III, Wakayama Medical University, 811-1, Kimiidera, Wakayama-city, Wakayama, 641-8501, Japan.
  • Kanai K; Internal Medicine III, Wakayama Medical University, 811-1, Kimiidera, Wakayama-city, Wakayama, 641-8501, Japan.
  • Hayata A; Internal Medicine III, Wakayama Medical University, 811-1, Kimiidera, Wakayama-city, Wakayama, 641-8501, Japan.
  • Tokudome N; Internal Medicine III, Wakayama Medical University, 811-1, Kimiidera, Wakayama-city, Wakayama, 641-8501, Japan.
  • Akamatsu K; Internal Medicine III, Wakayama Medical University, 811-1, Kimiidera, Wakayama-city, Wakayama, 641-8501, Japan.
  • Nakanishi M; Internal Medicine III, Wakayama Medical University, 811-1, Kimiidera, Wakayama-city, Wakayama, 641-8501, Japan.
  • Ueda H; Internal Medicine III, Wakayama Medical University, 811-1, Kimiidera, Wakayama-city, Wakayama, 641-8501, Japan.
  • Yamamoto N; Internal Medicine III, Wakayama Medical University, 811-1, Kimiidera, Wakayama-city, Wakayama, 641-8501, Japan.
Lung Cancer ; 132: 107-113, 2019 06.
Article en En | MEDLINE | ID: mdl-31097082
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Quimiocina CCL5 / Folistatina / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Quimiocina CXCL10 / Antineoplásicos Inmunológicos / Nivolumab / Enfermedades del Sistema Inmune / Neoplasias Pulmonares Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Quimiocina CCL5 / Folistatina / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Quimiocina CXCL10 / Antineoplásicos Inmunológicos / Nivolumab / Enfermedades del Sistema Inmune / Neoplasias Pulmonares Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article